Litigation Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA (D. Del. 2018)
✉ Email this page to a colleague
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA (D. Del. 2018)
| Docket | ⤷ Try a Trial | Date Filed | 2018-03-12 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Defendant | Referred To | |
| Parties | LUPIN ATLANTIS HOLDINGS SA | ||
| Patents | 9,561,251 | ||
| Attorneys | John C. Phillips , Jr. | ||
| Firms | Farnan LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA
The small molecule drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Vifor Fresenius Medical Care Renal Pharma Ltd. v. Lupin Atlantis Holdings SA (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-03-12 | 1 | infringement of U.S. Patent Nos. 6,174,442 (“the ’442 patent”) and 9,561,251 (“the ’251 patent”) (collectively…On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled “Pharmaceutical compositions.… THE PATENTS-IN-SUIT 7. On January 16, 2001, the United States Patent and Trademark…Switzerland is the assignee of the ’442 patent. A copy of the ’442 patent is attached hereto as Exhibit A. …is the assignee of the ’251 patent. A copy of the ’251 patent is attached hereto as Exhibit B. | External link to document | |
| 2019-09-05 | 114 | Opinion - Memorandum Opinion | infringement of U.S. Patent No . 9,561 ,251 (the '" 251 Patent"). (D.I. 1) The patent-in-suit relates…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent "specification…strength) are addressed in the Patent (D.I. 77 at ,r 12) (citing '251 Patent, col. 1411. 51-52), and …ultimate question of the proper construction of a patent is a question of law. See Teva Pharm. USA, Inc | External link to document |
| 2019-09-11 | 117 | Complaint - Amended | THE ’251 PATENT 7. On February 7, 2017, the PTO issued U.S. Patent No. 9,561,251, entitled…This is an action for infringement of U.S. Patent No. 9,561,251 as corrected by the Certificate of Correction… of Correction regarding the ’251 patent. A copy of the ’251 patent, as corrected by the Certificate … in prior patent cases. On information and belief, Lupin Atlantis has been sued for patent infringement… ) FIRST AMENDED COMPLAINT FOR PATENT INFRINGEMENT Plaintiffs Vifor Fresenius | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
